Autophagy, a cellular self-digestion process, involves the degradation of targeted cell components such as damaged organelles, unfolded proteins, and intracellular pathogens by lysosomes. It is a major quality control system of the cell and plays an important role in cell differentiation, survival, development, and homeostasis. Alterations in the cell autophagic machinery have been implicated in several disease conditions, including neurodegeneration, autoimmunity, cancer, infection, inflammatory diseases, and aging. In non-alcoholic fatty liver disease, including its inflammatory form, non-alcoholic steatohepatitis (NASH), a decrease in cell autophagic activity, has been implicated in the initial development and progression of steatosis to NASH and hepatocellular carcinoma (HCC). We present an overview of autophagy as it occurs in mammalian cells with an insight into the emerging understanding of the role of autophagy in NASH and NASH-related HCC.
CITATION STYLE
Udoh, U. A. S., Rajan, P. K., Nakafuku, Y., Finley, R., & Sanabria, J. R. (2022, July 1). Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms23147734
Mendeley helps you to discover research relevant for your work.